WHO R&D Blueprint: novel Coronavirus: prospects for evaluating cross-reactivity of nCoV with SARS-CoV
27 January 2020
| COVID-19: Laboratory and diagnosis
Overview
Objectives of the call
- To discuss the theoretical potential for cross-reactivity between nCoV and SARS based on available sequence/modelling data
- To obtain an overview of the status of development/availability of critical materials and reagents needed to formally evaluate cross-reactivity between nCoV and SARS in the laboratory
- To discuss the key elements of experimental design for evaluating crossreactivity
o To agree on critical next steps to provide guidance in this area of work.
WHO Team
R&D Blue Print (RDB),
WHO Headquarters (HQ)
Number of pages
6
Reference numbers
WHO Reference Number: WHO/HEO/R&D Blueprint (nCoV)/2020.3